Mitochondrial Transplants to Treat Mitochondrial Dysfunction
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Sagan L
. On the origin of mitosing cells. J Theor Biol. 1967; 14(3):255-74.
DOI: 10.1016/0022-5193(67)90079-3.
View
2.
Suomalainen A, Battersby B
. Mitochondrial diseases: the contribution of organelle stress responses to pathology. Nat Rev Mol Cell Biol. 2017; 19(2):77-92.
DOI: 10.1038/nrm.2017.66.
View
3.
Nakai R, Varnum S, Field R, Shi H, Giwa R, Jia W
. Mitochondria transfer-based therapies reduce the morbidity and mortality of Leigh syndrome. Nat Metab. 2024; 6(10):1886-1896.
DOI: 10.1038/s42255-024-01125-5.
View
4.
Di Meo I, Marchet S, Lamperti C, Zeviani M, Viscomi C
. AAV9-based gene therapy partially ameliorates the clinical phenotype of a mouse model of Leigh syndrome. Gene Ther. 2017; 24(10):661-667.
PMC: 5658670.
DOI: 10.1038/gt.2017.53.
View
5.
Ito T, Lu C, Khan J, Nguyen Q, Huang H, Kim D
. Hepatic S6K1 Partially Regulates Lifespan of Mice with Mitochondrial Complex I Deficiency. Front Genet. 2017; 8:113.
PMC: 5585733.
DOI: 10.3389/fgene.2017.00113.
View